Navigation Links
Parker Waichman LLP Commends Arkansas Attorney General for Backing Fine Against Johnson & Johnson over Risperdal Off-Label Marketing Allegations
Date:6/21/2013

New York, NY (PRWEB) June 21, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, notes that a number of lawmakers are telling the Arkansas Supreme Court to uphold the $1.2 billion fine imposed on Johnson & Johnson (J&J) by a lower court for off-label marketing claims related to the company’s antipsychotic drug Risperdal, according to a June 18 Associated Press report published on WashingtonPost.com.

As noted in the report, state Attorney General Dustin McDaniel called on the state’s Supreme Court justices to reject J&J’s appeal of the lower court’s ruling in which the drug maker was found to have downplayed and hid risks associated with Risperdal use (State of Arkansas v. Ortho-McNeil-Janssen Pharmaceuticals Inc., case no: CV07-15345). Numerous supporters have emerged to back the lower court’s decision, including 35 state attorneys general, 65 Arkansas lawmakers, as well as former U.S. Food and Drug Administration (FDA) Commissioner Donald Kennedy, the report added.

The allegations that J&J had made off-label marketing claims centered on the company’s effort to prompt doctors to prescribe Risperdal for children before the FDA had approved the drug for use by children, according to an August 30, 2012, Reuters report. The FDA initially approved Risperdal for use by adults, in 1993; it wasn’t approved for children until 1997. As the Reuters article related, drug makers can only legally promote their drugs for FDA-approved uses. Doctors, on the other hand, are free to prescribe a drug for any reason they see fit – when it is for something not approved by the FDA, it is called using the drug “off-label.”

Risperdal is an antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and acute mania associated with autistic disorders. It has been linked to side effects such as male breast growth, known as gynecomastia. On April 1, 2006, the Journal of Clinical Psychopharmacology published a report releasing its findings that levels of prolactin – which is the hormone that stimulates milk production – are increased in Risperdal users. Parker Waichman LLP is offering free case evaluations for patients who took Risperdal and suffered from gynecomastia and other unexpected side effects. Symptoms of gynecomastia, as defined by the Mayo Clinic on its website, include:

  •     Swelling
  •     Pain
  •     Tenderness
  •     Nipple discharge in one or both breasts

Parker Waichman LLP continues to offer free lawsuit consultations to victims of Risperdal side effects. If you or a loved one experienced complications following POP and SUI surgery with mesh, please visit the firm's Risperdal Side Effects page at yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636)

Contact: Parker Waichman LLP
                 Gary Falkowitz, Managing Attorney
                 (800) LAW-INFO
                 (800) 529-4636
                 http://www.yourlawyer.com

Read the full story at http://www.prweb.com/releases/risperdal_arkansas_fine/06/prweb10859554.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. San Bruno, CA Dentist Dr. Bradley Parker Receives Top Reviews for New Laser Assisted Dental Treatments
2. YourPleasurableSecrets.com, a leading retailer of Pipedream Products, Adult Toys & Novelties, is replenishing their lineup of adult movies Kay Parker has starred in.
3. In Light of Alleged Deceptive Marketing Claims Made by Drug Makers, Parker Waichman LLP Addresses Issues Allegedly Related to the Safety and Effectiveness of Plavix
4. Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Responds to Doctor’s Testimony Alleging Intuitive Surgical’s Robotic Device Contributed to a Man’s Death
5. Wisconsin Woman Alleges She was Injured by Transvaginal Mesh Devices in Lawsuit Filed by Parker Waichman LLP
6. Parker Waichman LLP Files Class Action Lawsuit on Behalf of Consumers Who’ve Purchased Azek Decking
7. Texas Woman Alleges Actos Caused her Bladder Cancer, Parker Waichman LLP Files Lawsuit on Victim’s Behalf
8. In Light of New Research Findings, Parker Waichman LLP Warns about Risk of Texting While Driving
9. New York Woman Suffers Injuries Allegedly Due to Boston Scientific’s Transvaginal Mesh Device, Lawsuit Filed by Parker Waichman LLP
10. Missouri Man Alleges Five Years of Actos Use Caused his Bladder Cancer; Parker Waichman LLP Files Lawsuit on Victim’s Behalf
11. Parker Waichman LLP Responds to an Intuitive Surgical Notice that the da Vinci Surgical Robot, Due to a Defect, Can Electrically Burn a Patient During Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: